Preparation method for salt of cyclic carbonate nucleoside compound and crystal form thereof
Stable cyclic carbonate nucleoside compounds were prepared by forming salts with acids, especially hydrobromide, which solved the problems of poor stability and water solubility of cyclic carbonate nucleoside compounds at room temperature, and enabled effective treatment of viruses such as the novel coronavirus.
Patent Information
- Application Number
- PCT/CN2024/113198
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-06
- Filing Date
- 2024-08-19
- Publication Date
- 2026-02-12
AI Technical Summary
Existing cyclic carbonate nucleoside compounds are viscous gels at room temperature, poorly soluble in water, have poor chemical stability and poor drug-like properties, and are difficult to effectively treat diseases caused by novel coronavirus, feline infectious peritonitis virus, respiratory syncytial virus, and porcine epidemic diarrhea virus.
By forming salts with various acids, especially hydrobromide, cyclic carbonate nucleoside compound salts with crystal form A or crystal form B are prepared, thereby improving their physical and chemical stability, water solubility and solid properties, reducing hygroscopicity, and enhancing oral bioavailability.
The prepared cyclic carbonate nucleoside compound salts exhibit good physical and chemical stability, significantly improved water solubility, reduced hygroscopicity, and enhanced oral bioavailability, making them suitable for treating diseases caused by novel coronavirus, feline infectious peritonitis virus, respiratory syncytial virus, and porcine epidemic diarrhea virus.